Back to Search Start Over

Taiwan ocular inflammation society consensus recommendations for the management of juvenile idiopathic arthritis-associated uveitis

Authors :
Wei-Dar Chen
Cheng-Hsiu Wu
Po-Yi Wu
Chang-Ping Lin
Liang-Shiou Ou
De-Kuang Hwang
Shwu-Jiuan Sheu
Wei-Yu Chiang
Yo-Chen Chang
Chun-Ju Lin
Wei-Chun Chan
Yueh-Fu Fang
Jerry Chien-Chieh Huang
Tzu-En Kao
Fang-Yi Chiu
Ning-Yi Hsia
Yih-Shiou Hwang
Source :
Journal of the Formosan Medical Association, Vol 123, Iss 12, Pp 1218-1227 (2024)
Publication Year :
2024
Publisher :
Elsevier, 2024.

Abstract

We presented the development of a consensus guideline for managing juvenile idiopathic arthritis-associated uveitis (JIAU) in Taiwan, considering regional differences in manifestation and epidemiology. The Taiwan Ocular Inflammation Society (TOIS) committee formulated this guideline using a modified Delphi approach with two panel meetings. Recommendations were based on a comprehensive evidence-based literature review and expert clinical experiences, and were graded according to the Oxford Centre for Evidence-Based Medicine's “Levels of Evidence” guideline (March 2009). The TOIS consensus guideline consists of 10 recommendations in four categories: screening and diagnosis, treatment, complications, and monitoring, covering a total of 27 items. These recommendations received over 75% agreement from the panelists. Early diagnosis and a coordinated referral system between ophthalmologists and pediatric rheumatologists are crucial to prevent irreversible visual impairment in children with JIAU. However, achieving a balance between disease activity and medication use remains a key challenge in JIAU management, necessitating further clinical studies.

Details

Language :
English
ISSN :
09296646
Volume :
123
Issue :
12
Database :
Directory of Open Access Journals
Journal :
Journal of the Formosan Medical Association
Publication Type :
Academic Journal
Accession number :
edsdoj.2e418fef2f5c4fe18177e2944d5f24e3
Document Type :
article
Full Text :
https://doi.org/10.1016/j.jfma.2024.02.010